List of figures and tables
About the Editors and Contributors
Woodhead Publishing Series in Biomedicine
Chapter 1: The bioscience sector: challenges and opportunities
Chapter 2: Academic innovation: so you want to be a bio-entrepreneur?
Chapter 3: Leadership and you
Chapter 4: Managing self, situations and stress
Chapter 5: It's all in the plan
Chapter 6: Exploring funding routes for therapeutics firms
Chapter 7: Raising funds and managing finances
Chapter 8: Introduction to intellectual property
Chapter 9: Managing projects and portfolios in R&D: why and how
Chapter 10: Successful registration of new therapies in the EU and USA
Chapter 11: Clinical trials: design and practice
Chapter 12: Business development: starting out
Chapter 13: Business development: to the deal and beyond
Chapter 14: Conclusions and final thoughts
A biotech manager's handbook lays out - in a simple, straightforward manner - for the manager or would-be entrepreneur the basic principles of running a biotech company. Most managers in biotechnology companies are working in their first company or in their first managerial role. Their expertise and experience in the scientific part of the work can be taken as a given but there is a whole range of other skills to be learned and areas of expertise to come to terms with. Small companies do not have big budgets to hire people or time to become an expert in so many areas. The book starts by outlining the state of the biopharmaceutical industry and goes on to explain the importance of planning (no matter what the size of the company). Succeeding chapters deal with the basics of intellectual property, perspectives from a university technology transfer office and how to raise some initial funding from an investor and entrepreneur.
- No other 'how to' manual exists for this sector
- Written by a range of expert professionals in each area, all in one book
- Is the only 'bench to bedside' book covering the whole spectrum of development
Biotechnologists in areas away from major biotech clusters; Managers/entrepreneurs of biotech companies; Pharmaceutical MBA candidates
- No. of pages:
- © Woodhead Publishing 2012
- 2nd May 2012
- Woodhead Publishing
- eBook ISBN:
- Hardcover ISBN:
Dr Michael O'Neill has had a career of more than 20 years working in neuroscience research in the pharmaceutical industry, working for Merck, Laboratorios Almirall and Eli Lilly. Michael's career has given him an expert knowledge of neuroscience balanced with a strong grasp of strategic principles drug discovery and development. Michael has authored over 80 papers, book chapters, patents and abstracts. He has presented his work at major international scientific conferences. He has held an adjunct appointment and has supervised PhD students at various leading universities. Michael is an accomplished research leader with extensive program and portfolio management experience. He has lead specialist and multidisciplinary teams in the UK, Europe and in the US. As a consultant Michael has helped companies of all sizes from university start-ups to Fortune 500 companies. This book is the distillation of all that experience.
Eolas Biosciences Limited
Michael Hopkins is a biologist is currently a Research Fellow at Science Policy research Unit, University of Sussex, and a Visiting Research Fellow at Cass Business School (London). He specialises in the study of innovation systems related to innovations in healthcare, spanning public and private sectors, products (e.g. drugs) and services (e.g. diagnostic testing). He has published widely in natural science and social science fields on the role of intellectual property, regulation and finance in innovation (including in Nature, Nature Biotechnology and Research Policy - the top journals in their respective fields). From 2004-2006 Michael was a Research Fellow of the Economic & Social Research Council and Medical Research Council. Additionally he has worked on a wide range of research projects funded by the European Commission's framework programmes, and Joint Research Centre, the UK's Engineering and Physical Sciences Research Council, the National Endowment for Science Technology and the Arts, the UK's Department of Trade and Industry, Human Genetics Commission and Strategic Advisory Board for Intellectual Property.
University of Sussex, UK